|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Impairment loss on intangible assets | |||||
| Restructuring and other costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Other comprehensive gain (loss): | |||||
| Unrealized (loss) gain on investments, net of tax of $0 | |||||
| Foreign currency translation adjustments | |||||
| Total other comprehensive (loss) gain | |||||
| Total comprehensive loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...